๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

P.2.064 A dose-ranging study of aripiprazole treatment in patients with psychosis associated with Alzheimer's dementia

โœ Scribed by D. Kostic; C. Breder; R. Swanink; R. Marcus; T. Iwamoto; W. Carson; R. McQuade

Book ID
118590646
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
117 KB
Volume
14
Category
Article
ISSN
0924-977X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Open-label flexible-dose pilot study to
Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease
โœ Joseph H. Friedman; Robert M. Berman; Christopher G. Goetz; Stewart A. Factor; W ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 57 KB ๐Ÿ‘ 2 views

## Abstract Psychosis affects at least 5% to 8% of medicationโ€treated patients with idiopathic Parkinson's disease (PD). Treatment options include reducing medications used for the treatment of PDโ€related motor symptoms or introducing an atypical antipsychotic drug. Only clozapine has been demonstr

Olanzapine versus placebo in the treatme
Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's disease
โœ Peter Paul De Deyn; Manuel Martรญn Carrasco; Walter Deberdt; Claude Jeandel; Dona ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 136 KB ๐Ÿ‘ 2 views

## Abstract ## Objectives Psychotic symptoms and behavioral disturbances are a concern in the care of elderly patients with Alzheimer's dementia (AD). This study was conducted to compare the efficacy of olanzapine versus placebo in patients with psychotic symptoms associated with AD in longโ€term o